Immunic Inc. (IMUX) Tops Q3 EPS by 2c

Immunic Inc. (NASDAQ: IMUX) reported Q3 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Nasdaq president says SK Hynix blockbuster IPO to draw foreign firms to US
• Timwood Holdings files for 5.6M share IPO at $4-$6/sh